An Evolution in the Treatment of Resistant Hypertension
Hypertension affects more than 1 billion people worldwide.4-6 Approximately nine out of 10 people are likely to develop hypertension at some point in their lifetime.7 Hypertension is the leading risk factor for mortality worldwide, causing an estimated 7.5 million deaths per year (13 percent of all deaths) as a result of cardiovascular, cerebrovascular and renal events.8
Resistant hypertension presents a special challenge, as it does not respond to standard treatments such as pharmaceutical therapies. Despite advances in such approaches, approximately 12.8 percent of treated hypertension patients have hypertension that is “uncontrolled” (consistently elevated despite lifestyle modifications and the aggressive use of medications).9
At St. Jude Medical, we research, design and develop cutting-edge diagnostic and therapeutic solutions for the treatment of resistant hypertension—with the goal of making therapy more efficient, thus reducing hospital costs.